Drug intelligence / Profile preview

allogeneic decalcified bone matrix

Development stage
Unknown
Lead developer
LifeNet Health
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Surgical Implantation, Intraosseous, Periodontal
01

Overview

Allogeneic decalcified bone matrix is a biologically derived graft material prepared from donor (allogeneic) human or animal bone that has been processed to remove mineral content (decalcification), typically using acid treatment. The resulting material retains the organic collagenous scaffold and non-collagenous proteins, including growth factors such as bone morphogenetic proteins (BMPs). This structure provides osteoconductive and osteoinductive properties—supporting new bone formation by serving as a scaffold for cell attachment and migration while also inducing differentiation of mesenchymal cells into chondrocytes and osteoblasts. Allogeneic DBM is used in orthopedic surgery, dental procedures, and tissue engineering for the repair of bony defects due to its biocompatibility, biodegradability, and ability to promote new bone growth[1][2][5][7]. It is not a single pharmaceutical compound but rather a processed biological tissue product.

Brand names
DBM PuttyDBM GelPutty Plus
Other names
allogenic decalcified bone matrixallogeneic demineralized bone matrixDBMABM

Beyond the preview

Go deeper on allogeneic decalcified bone matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic decalcified bone matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call